Astria Therapeutics Stock (NASDAQ: ATXS) stock price, news, charts, stock research, profile.
Open | $10.150 |
Close | - |
Volume / Avg. | 3.205K / 1.014M |
Day Range | 10.130 - 10.150 |
52 Wk Range | 4.260 - 16.900 |
Market Cap | $556.269M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 9.55% |
Days to Cover | 6.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Astria Therapeutics (NASDAQ: ATXS) through any online brokerage.
Other companies in Astria Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
The latest price target for Astria Therapeutics (NASDAQ: ATXS) was reported by Wedbush on Friday, May 10, 2024. The analyst firm set a price target for 22.00 expecting ATXS to rise to within 12 months (a possible 117.18% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Astria Therapeutics (NASDAQ: ATXS) is $10.13 last updated Today at May 10, 2024 at 9:30 AM EDT.
There are no upcoming dividends for Astria Therapeutics.
Astria Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Astria Therapeutics.
Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.